One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Is there a FUTURE for urodynamic testing in refractory overactive bladder syndrome?
Antenatal multiple micronutrient supplements: time for alignment to support country action
Safeguarding patient and provider rights in an era of US anti-immigration policies
Ethical challenges in cancer registries: public benefits and patient rights
Decolonising global health funding: local leadership for global impact
COVID-19: border closures violate human rights – Authors' reply
Neoadjuvant therapy in HER2-positive breast cancer and interim PET
Neoadjuvant therapy in HER2-positive breast cancer and interim PET – Authors' reply
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial
Behavioural interventions to increase uptake of FIT colorectal screening in Scotland (TEMPO): a nationwide, eight-arm, factorial, randomised controlled trial
Neuroprotective mechanisms of exercise and the importance of fitness for healthy brain ageing
